A systematic review of the effectiveness of contrast-enhanced ultrasound using SonoVue compared with contrast-enhanced CT and contrast-enhanced MRI was undertaken by the external assessment group. The ...
MILAN, Aug. 5, 2025 /CNW/ -- Bracco Imaging, a global leader in diagnostic imaging, today announced that its ultrasound contrast agent SonoVue ® has been approved by the China's National Medical ...
Bracco Imaging, a global leader in diagnostic imaging, announced that its ultrasound contrast agent SonoVue has been approved by the China's National Medical Products Administration (NMPA) for use in ...
Allogeneic PBSCT is a well-established treatment modality for a variety of nonmalignant and malignant disorders. Acute GVHD is a major complication after allo-SCT, and can cause severe damage to skin, ...
The diagnostics advisory committee reviewed the evidence on the clinical and cost effectiveness of contrast-enhanced ultrasound with SonoVue and noted that the technology was assessed in 3 clinical ...
New indication of SonoVue ® supports non-invasive assessment of female infertility through contrast-enhanced ultrasound in China MILAN, Aug. 6, 2025 /PRNewswire/ -- Bracco Imaging, a global leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results